Did you know there’s even more we can do to promote your episode? Find out more…
Matthew Bio, CSO of Cambrex & President of Snapdragon Chemistry, shares insights on pharma outsourcing, continuous manufacturing, and leadership.
Sara Tylosky, CEO at Farmacon Global, joins us to discuss rare disease trials, patient access, and LATAM’s growing pharma role.
Ray Pressburger, Senior Managing Director at Accenture, joins Raman to explore the top five themes shaping the strategies of big pharma CEOs.
Luke Bilton, Co-Founder of Life Science Networks, talks about the crucial role of events in pharma outsourcing in his recent chat with Raman.
Retired industry veteran Robert Bottome shares his unique insights on pharma logistics and supply chains after years of impactful work.
Imran Kausar, Founder of DeepHealth Consulting, joins the podcast to discuss gene therapies, their pricing, and the value they bring to patients.
James Lovett & Mike Cohen from Myonex join the podcast to share insights on driving success in clinical trials and fueling sustainable organic growth.
Dean McAlister, EVP at Inizio Biotech, joins the podcast live from J.P. Morgan 2025 to share insights on the life sciences sector outlook.
Discover what makes Piramal Global Pharma a standout in the CDMO space as CEO Peter DeYoung reveals their “secret sauce” to success.
Ian Tzeng, Managing Director & Partner at L.E.K., joins the podcast to discuss the outlook for 2025 in the pharma services sector.
